Bloomage Biotechnology Corporation Limited’s Net Profit Rose 1.7% in First Quarter of 2023
Listen to the full version

Bloomage Biotechnology Corporation Limited (华熙生物科技股份有限公司) (688363.SH) reported a net profit of 201 million yuan in the first quarter of 2023, up 1.7% year-on-year.
Meanwhile, the company posted 1.3 billion yuan in revenue, up 4% year-on-year.
At the end of the reporting period, it had 8.5 billion yuan in total assets and 1.5 billion yuan in total liabilities, with a liability-to-asset ratio of 18%.
Unlock exclusive discounts with a Caixin group subscription — ideal for teams and organizations.
Subscribe to both Caixin Global and The Wall Street Journal — for the price of one.
- PODCAST
- MOST POPULAR